Tag Archives: Nimbus Therapeutics

← Older posts

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

Scan the landscape of experimental medicines in development today and you’ll spot Schrödinger’s handiwork. The company’s software has helped discover compounds that are now advancing in the pipelines of several drug developers. Schrödinger isn’t shying away from that work. But as it continues building its own drug pipeline, it’s now laying out plans to go […]

Posted in Boston blog main, Boston top stories, National blog main, New York, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

The life science and healthcare worlds are vast. We often talk about impact in terms of millions of patients and billions of dollars. But these worlds can be small, too. It seems at times we’re never far removed from any one person, through their published papers, social media connections, friends, colleagues, or people they’ve mentored. […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More

Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow

The 2nd annual Xconomy Awards Gala was a who’s who of Boston biotech. About 400 people from across the life science ecosystem came out to Boston’s Hynes Convention Center last month to celebrate the finalists over dinner and drinks, find out who got to take home the awards, and reconnect with friends and colleagues. It […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow

Introducing the 2018 Innovation at the Intersection Award Finalists

From artificial intelligence (A.I.) to materials science, this year’s Xconomy Awards finalists in the Innovation at the Intersection category are bringing a variety of disciplines outside of biology to bear on tough problems in life science. The hope is that advanced algorithms, novel biomaterials, and digital technologies will make drug discovery more efficient, cancer immunotherapies […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Introducing the 2018 Innovation at the Intersection Award Finalists

With $45M, HotSpot Takes Drug Research to New Biological Real Estate

In real estate, location is key. The same holds true in the hunt for new drugs. HotSpot Therapeutics is trying to break new ground in drug discovery by hitting locations on a protein that aren’t the conventional targets of most medicines. HotSpot is now emerging from stealth with preclinical compounds that could become new treatments […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on With $45M, HotSpot Takes Drug Research to New Biological Real Estate

The 2018 Xconomy Awards Finalists Are…

[Updated 6/28/18 5:20pm ET; see note below] There was discussion. There was debate. After much wrangling, the editors and judges have narrowed down the impressive list of nearly 300 nominees for the 2018 Xconomy Awards to an all-star group of 64 finalists in 11 categories. There is no doubt that the overall caliber of the […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on The 2018 Xconomy Awards Finalists Are…

Nimbus Nabs $65M to Advance In-House Drug Discoveries to the Clinic

Nimbus Therapeutics’ drugs have already found new homes with larger companies that aim to develop them into potential treatments for autoimmune and liver diseases. Selling its discoveries was a goal for Nimbus from its inception. But the Cambridge, MA, biotech has also been trying to forge its own identity framed around discoveries that it keeps […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, New York blog main, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Nimbus Nabs $65M to Advance In-House Drug Discoveries to the Clinic

Relay Tx Raises $63M to Advance Protein Motion Drugs Into the Clinic

Proteins play important roles in cells, folding and changing their shape to perform various biological functions. While many of these shapes are important to healthy cell function, some shapes are linked to disease, says Sanjiv Patel, CEO of Relay Therapeutics. Relay has developed a way to see this protein motion, and use that moving image […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on Relay Tx Raises $63M to Advance Protein Motion Drugs Into the Clinic

15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)

Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy, the first FDA application for a gene therapy or a medicine using RNA interference. There were also stinging failures, such as the latest in a long […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on 15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)

Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More

Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. She was 67. First at the University of Chicago and then MIT’s Whitehead Institute, Lindquist helped biologists see that all kinds of organisms—including ourselves—share errors of protein folding […]

Posted in Boston blog main, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More← Older posts